1 / 6
Verified Lab Results
Finished in the USA
Research Use OnlyGLP Peptides · Popular Peptides
$144.00$72.00Save 50%
GLYCON X is a laboratory research peptide built from 39 amino acids that acts at two receptors central to metabolism research: GLP-1 and GIP.
Laboratories work with it in cell and rodent studies of insulin-secretion dynamics, incretin receptor pharmacology, and energy-balance and satiety signalling. It ships as a sealed vial of freeze-dried powder for research use only.
Quantity
$72.00
GLYCON-X™ · 15mg
$72.00$144.00
Bundle & save
For Research Use Only. Not for human consumption or therapeutic treatment.
Compound Class and Structure
GLYCON X is a synthetic 39-amino-acid peptide in the incretin-mimetic class of laboratory research materials. Its backbone follows the glucagon superfamily architecture shared by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), with substitutions and a lipidation handle that support extended plasma residence in rodent work and stability against dipeptidyl peptidase-4 cleavage at the N-terminus. The material is supplied as a sterile-filtered, lyophilised white powder sealed under vacuum in glass vials, offered in 15mg, 30mg and 60mg fills.
Receptor Pharmacology and Signalling
In cell-based characterisation, GLYCON X behaves as a dual agonist at the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), two class B1 G-protein-coupled receptors. Engagement of either receptor couples principally to Gαs, elevating intracellular cyclic AMP and activating protein kinase A together with the Epac2/Rap1 axis. Secondary readouts include β-arrestin-1/2 recruitment, receptor internalisation and recycling kinetics, and ERK1/2 phosphorylation. Because one molecule addresses two receptor populations, investigators use GLYCON X to interrogate potency ratios (EC50 comparisons across GLP-1R and GIPR), signal bias between cAMP and arrestin arms, cross-desensitisation, and whether combined incretin input behaves additively or synergistically relative to single-receptor ligands.
Research Areas and Measured Endpoints
Insulin-secretion dynamics is the most common application: perifused isolated rodent islets and clonal β-cell lines such as INS-1 832/13 and MIN6, with glucose-stimulated insulin secretion quantified by ELISA, alongside intracellular calcium imaging, mitochondrial membrane potential and secretory granule exocytosis assays. Incretin receptor pharmacology work uses HEK293 or CHO lines stably expressing human GLP-1R or GIPR for competition binding, HTRF or BRET cAMP accumulation, arrestin recruitment and concentration-response curve fitting. Energy-balance and satiety signalling studies in rodent models record food-intake profiles from automated feeding monitors, indirect calorimetry variables including oxygen consumption and respiratory exchange ratio, gastric-emptying kinetics, and c-Fos immunoreactivity mapping across hypothalamic and hindbrain nuclei. Transcriptomic and immunoblot panels extend these endpoints to receptor expression and downstream effector abundance. In every case the measured quantity is an assay signal or animal-model parameter, not a therapeutic outcome.
Storage of the Lyophilised Material
For laboratory records, the sealed lyophilised vial tolerates short ambient-temperature transit intervals without loss of integrity. Long-term storage is documented at -20 C, with -80 C used for extended archival holding of reference lots. Vials are kept in the dark or in amber secondary packaging, since peptide bonds and aromatic residues are light-sensitive. Desiccated conditions matter: the powder is hygroscopic, so vials are held with desiccant, kept upright, and left sealed with the stopper and crimp undisturbed until the material enters a documented workflow. Repeated temperature cycling of the container is avoided, and freezer logs typically note receipt date, lot identifier and storage location so that each vial can be traced back to its certificate of analysis.
Compliance Statement
GLYCON X is distributed strictly as a research-use-only laboratory material for qualified professionals working in controlled facilities. It is not a medicine, supplement, food or cosmetic ingredient, and it is not intended for human or veterinary application. All descriptions above summarise published incretin-biology literature and internal analytical documentation for laboratory reference purposes only.
GLYCON X is a synthetic 39-amino-acid peptide developed as a research tool for incretin biology. Structurally it draws on the glucagon superfamily template that underlies both GLP-1 and GIP, and in receptor assays it activates the GLP-1 receptor and the GIP receptor within the same experiment rather than requiring two separate ligands.
The name reflects its principal research setting: glycaemic-regulation modelling in cells and rodents, with the X marking the dual-receptor design. Laboratories apply it across three broad fields, namely insulin-secretion dynamics in islets and clonal β-cell lines, incretin receptor pharmacology in transfected reporter systems, and energy-balance and satiety signalling in rodent metabolic models.
Material is supplied as a lyophilised powder in sealed glass vials at 15mg, 30mg and 60mg fills. It is a laboratory reagent only, with no human or veterinary application of any kind.
Real Peptides supplies GLYCON X on a documentation-first basis. Every lot is submitted to an independent analytical laboratory, and the resulting certificate of analysis is published against that specific lot rather than presented as a generic sample document. Identity and purity data are therefore traceable from the vial label back to the testing report.
Vials arrive sealed, with intact stoppers and crimps, and the lot identifier printed on the label so it can be matched to the corresponding certificate and entered into laboratory inventory records. Fills are offered at 15mg, 30mg and 60mg so that project scale can be matched to the material actually required.
Stock is held and dispatched within the United States, which shortens transit intervals for the lyophilised powder and keeps chain-of-custody documentation simple. Support enquiries about analytical paperwork or lot traceability are answered by the team that maintains those records.
The distinguishing feature is mechanism class. Single-receptor incretin research peptides engage GLP-1R alone and produce a signalling profile confined to one receptor population, while GIPR-selective ligands isolate the opposite arm. GLYCON X occupies the dual-agonist class, letting investigators observe both arms from one molecule and compare integrated output with the arithmetic sum of two separate single-receptor ligands.
That design matters for experiments in pharmacological interaction. Cross-desensitisation, differential internalisation rates between the two receptors, and divergence between cAMP potency and β-arrestin recruitment all become measurable within a single concentration-response series rather than across pooled datasets.
It also sits apart from broader multi-agonist classes that add glucagon receptor activity, and from amylin-class or leptin-pathway tools that act through unrelated receptor families. For studies scoped specifically to incretin receptor crosstalk, the two-receptor boundary of GLYCON X keeps the pharmacological variable clearly defined.
GLP Peptides compounds
Ships within 24 hours
Free standard shipping on orders $250+
Lab report included
